Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
Más filtros

Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
J Endocrinol Invest ; 33(9): 599-602, 2010 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-21099246

RESUMEN

BACKGROUND: Ghrelin is a gastric secreted hormone deeply implicated in meal initiation and body weight regulation. This peptide is a peripheral orexigenic hormone with a nutritional status-dependent regulation showing a pre-pandrial rise and post-prandial fall pattern. A wide variety of studies have tested the effect of meal different nutrient composition over stomach mucosa ghrelin content and plasmatic ghrelin levels; nevertheless, few and non-conclusive data exist about the direct action of macronutrients on the stomach in order to regulate ghrelin secretion. The recent identification of taste receptors or chemoreceptors in the stomach mucosa would reinforce this paradigm. AIMS: To investigate the individual effect of different macronutrients (l-glutamine, lipids, and glucose) over gastric ghrelin secretion by using an in vitro gastric explants model. RESULTS: L-glutamine and intralipid emulsion act locally in the stomach decreasing ghrelin secretion, while no effect was found after glucose exposure. CONCLUSIONS: These results show for the first time that macronutrients, and specially amino acids and lipids, act directly in the stomach in order to regulate gastric ghrelin release. Consequently, the chemosensory capacity of the stomach, until now restricted to the oral cavity or intestine, is demonstrated.


Asunto(s)
Alimentos , Mucosa Gástrica/metabolismo , Ghrelina/metabolismo , Estómago/efectos de los fármacos , Animales , Células Cultivadas , Ingestión de Alimentos/fisiología , Emulsiones/farmacología , Mucosa Gástrica/efectos de los fármacos , Ghrelina/análisis , Glucosa/farmacología , Glutamina/farmacología , Lípidos/farmacología , Fosfolípidos/farmacología , Periodo Posprandial/efectos de los fármacos , Ratas , Ratas Sprague-Dawley , Aceite de Soja/farmacología
2.
J Neuroendocrinol ; 22(11): 1127-36, 2010 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-20807320

RESUMEN

The somatotroph axis is a crucial pathway regulating metabolism. Despite the fact that the endocannabinoid system has been also revealed as a potent modulator of energy homeostasis, little information is available concerning a putative interaction between these two systems. The aim of the present study was to determine the in vivo effects of the blockade of the cannabinoid receptor type 1 (CB1) over growth hormone (GH) secretion using the CB1 antagonist rimonabant. The results obtained show that the blockade of the CB1 peripheral receptor by i.p. injection of rimonabant significantly inhibited pulsatile GH secretion. Similarly, it was found that this injection significantly decreased ghrelin-induced GH secretion without any effect on growth hormone-releasing hormone (GHRH)-induced GH discharge. In situ hybridisation showed that the peripheral blockade of CB1 did not affect hypothalamic somatostatin mRNA levels; however, GHRH mRNA expression was significantly decreased. The blockade of the vagus nerve signal by surgical vagotomy eliminated the inhibitory action of rimonabant on GHRH mRNA and consequently on GH. On the other hand, the central CB1 blockade by i.c.v. rimonabant treatment was unable to reproduce the effect of peripheral blockade on GHRH mRNA, nor the GH response to ghrelin. In conclusion, the data reported in the present study establish, from a physiological point of view, the existence of a novel mechanism of GH regulation implicating the action of the cannabinoid receptor on the somatotroph axis.


Asunto(s)
Antagonistas de Receptores de Cannabinoides , Moduladores de Receptores de Cannabinoides/fisiología , Endocannabinoides , Ghrelina/fisiología , Hormona de Crecimiento Humana/metabolismo , Piperidinas/farmacología , Pirazoles/farmacología , Animales , Hormona Liberadora de Hormona del Crecimiento/metabolismo , Hipotálamo/metabolismo , Hibridación in Situ , Inyecciones Intraventriculares , Masculino , Vías Nerviosas/fisiología , Piperidinas/administración & dosificación , Pirazoles/administración & dosificación , ARN Mensajero/biosíntesis , ARN Mensajero/genética , Ratas , Ratas Sprague-Dawley , Receptor Cannabinoide CB1/antagonistas & inhibidores , Rimonabant , Somatostatina/metabolismo , Vagotomía , Nervio Vago/fisiología
3.
Int J Obes (Lond) ; 31(2): 371-7, 2007 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-16801924

RESUMEN

OBJECTIVE: To study the effect of perinatal programming and overfeeding on the hypothalamic control mechanisms of food intake in adult rats. DESIGN: Neonatal programming effects on body weight, food intake, central and peripheral leptin levels, hypothalamic neuropeptides, leptin receptors and central leptin responsiveness in adult rats. MEASUREMENTS: Plasma and cerebrospinal fluid (CSF) leptin levels were analyzed using radioimmunoassay. Neuropeptide mRNA levels were analyzed using in situ hybridization. Leptin receptor mRNA levels were analyzed using reverse transcriptase-polymerase chain reaction. RESULTS: Perinatally overfed rats growing up in small litters (SL) maintain their obese and hyperleptinemic phenotype in adulthood. However, leptin levels in CSF are abnormally low considering the plasmatic hyperleptinemia. In contrast to the already reported changes in perinatally overfed juvenile rats, perinatally overfed adult rats did not show any alteration in the expression of leptin receptor isoforms and evaluated neuropeptides. Moreover, SL adult rats showed a normal sensitivity regarding the inhibitory effect of intracerebroventricular leptin administration on food intake. CONCLUSION: Perinatal overfeeding does not induce alterations in either the anorectic response to central leptin administration or expression of leptin receptors and neuropeptides in adulthood. The leptin resistance to peripheral leptin in SL adult rats may be related to impaired leptin transport across the blood-brain barrier.


Asunto(s)
Ingestión de Alimentos/fisiología , Leptina/sangre , Animales , Barrera Hematoencefálica/fisiología , Tamaño Corporal/fisiología , Peso Corporal/fisiología , Ingestión de Alimentos/efectos de los fármacos , Femenino , Regulación de la Expresión Génica , Hipotálamo/metabolismo , Hibridación in Situ , Leptina/líquido cefalorraquídeo , Leptina/farmacología , Neuropéptidos/biosíntesis , Neuropéptidos/genética , Obesidad/sangre , Obesidad/líquido cefalorraquídeo , Obesidad/fisiopatología , Embarazo , ARN Mensajero/genética , Ratas , Ratas Sprague-Dawley , Receptores de Superficie Celular/biosíntesis , Receptores de Superficie Celular/genética , Receptores de Leptina , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa/métodos
4.
Diabetologia ; 48(1): 140-8, 2005 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-15616803

RESUMEN

AIM/HYPOTHESIS: Perinatal overfeeding predisposes humans and rats to obesity and diabetes in later life. One classical model for studying the effect of early feeding is manipulation of the size of rat litters. Rats growing up in small litters gain more weight than rats growing up in normal-sized litters. Interestingly, these obese rats maintain this phenotype in adulthood. Conversely, rats raised in large litters show a delay in growth and a decrease in body weight. The aim of this work was to assess the hypothalamic control mechanisms of food intake regulated by perinatal feeding. METHODS: Leptin levels were analysed using RIA. Leptin receptor mRNA levels were analysed using RT-PCR. Neuropeptide mRNA levels were analysed using in situ hybridisation. RESULTS: Perinatally overfed neonatal male rats exhibited hyperleptinaemia and a decrease in hypothalamic mRNA levels of the long isoform of the leptin receptor (OB-Rb), explaining their leptin resistance. Moreover, this obese model showed an increase in the mRNA expression of cocaine- and amphetamine-regulated transcript, neuropeptide Y and agouti-related protein in the hypothalamic arcuate nucleus (ARC). In contrast, perinatally underfed neonatal male rats with hypoleptinaemia showed an increase in hypothalamic mRNA of the short isoforms of the leptin receptor. Furthermore, they exhibited an increase in expression of neuropeptide Y and agouti-related protein in the ARC. CONCLUSIONS/INTERPRETATION: Rats overfed during early postnatal life show a leptin-resistant state mediated by down-regulation of the hypothalamic OB-Rb. These data, together with the increased expression of neuropeptide Y and agouti-related protein in specific neurons in the ARC, might indicate the existence of regulated programming in this nucleus and may provide a new aetiopathogenic concept in susceptibility to obesity.


Asunto(s)
Conducta Alimentaria/fisiología , Hipotálamo/fisiología , Neuropéptido Y/fisiología , Proteínas/fisiología , Receptores de Superficie Celular/fisiología , Envejecimiento/fisiología , Proteína Relacionada con Agouti , Alimentación Animal , Animales , Animales Lactantes , Secuencia de Bases , Motivos Nodales de Cisteina , Cartilla de ADN , Femenino , Hipotálamo/crecimiento & desarrollo , Hibridación in Situ , Péptidos y Proteínas de Señalización Intercelular , Leptina/sangre , Masculino , Conducta Materna , Embarazo , Isoformas de Proteínas/fisiología , ARN Mensajero/genética , Ratas , Ratas Sprague-Dawley , Receptores de Superficie Celular/genética , Receptores de Leptina , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa
5.
Rev Med Univ Navarra ; 48(2): 11-7, 2004.
Artículo en Español | MEDLINE | ID: mdl-15382608

RESUMEN

Ghrelin, the endogenous ligand for GHS-R, was isolated from rat stomach, although other tissues exist expressing ghrelin, such as pituitary, hypothalamus, placent, ovary, testes, etc. It was showed that ghrelin is implicated in GH secretion, in vivo and in vitro. There are direct evidences that proof that ghrelin administration induces GH secretion. There are in vivo data, showing ghrelin as a most potent GH secretor than GHRH. Evidences exist of ghrelin actions in the regulation of food intake and energy homeostasis. Ghrelin has a clear role in the differents pathologies such as obesity, anorexia and bulimia.


Asunto(s)
Conducta Alimentaria/fisiología , Trastornos de Alimentación y de la Ingestión de Alimentos/fisiopatología , Hormonas Peptídicas/fisiología , Proteína Relacionada con Agouti , Animales , Apetito/efectos de los fármacos , Apetito/fisiología , Metabolismo Energético/fisiología , Mucosa Gástrica/metabolismo , Ghrelina , Hormona del Crecimiento/metabolismo , Humanos , Hipotálamo/fisiología , Péptidos y Proteínas de Señalización Intercelular , Leptina/fisiología , Neuropéptido Y/fisiología , Hormonas Peptídicas/farmacología , Proteínas/fisiología , Ratas , Ratas Endogámicas Lew , Ratas Mutantes
6.
FASEB J ; 17(11): 1392-400, 2003 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-12890692

RESUMEN

Pregnancy and lactation provide excellent models of physiological hyperphagia and hyperprolactinemia. To identify possible factors associated with the increased feeding in these situations, we measured hypothalamic mRNA levels of three orexigenic neuropeptides--NPY, MCH, and orexins--in nonpregnant, pregnant, and lactating rats by in situ hybridization. NPY mRNA content in the arcuate nucleus was significantly increased during pregnancy and lactation. However, MCH and prepro-orexin expression was decreased in both states. 48 or 72 h of fasting in pregnant and lactating rats further elevated NPY mRNA levels and increased the low MCH mRNA content. Surprisingly, no effect was observed in prepro-orexin mRNA levels. Finally, we investigated the possible effect of high PRL levels on these orexigenic signals using a model of hyperprolactinemia induced by pituitary graft. NPY mRNA content was unchanged, but MCH and prepro-orexin mRNA levels were significantly decreased. Our results suggest that the increased NPY expression might be partly responsible for the hyperphagia observed during pregnancy and lactation. MCH and prepro-orexin may be involved in the adaptation of other homeostatic mechanisms and their decreased levels in these physiological settings could be mediated by the elevated circulating PRL levels.


Asunto(s)
Hiperfagia/etiología , Hormonas Hipotalámicas/biosíntesis , Hipotálamo/metabolismo , Melaninas/biosíntesis , Neuropéptido Y/biosíntesis , Neuropéptidos/biosíntesis , Hormonas Hipofisarias/biosíntesis , Precursores de Proteínas/biosíntesis , Animales , Femenino , Regulación de la Expresión Génica , Hiperfagia/genética , Hiperfagia/metabolismo , Hiperprolactinemia/etiología , Hiperprolactinemia/genética , Hiperprolactinemia/metabolismo , Hormonas Hipotalámicas/genética , Hipotálamo/citología , Hibridación in Situ , Péptidos y Proteínas de Señalización Intracelular , Lactancia , Melaninas/genética , Neuropéptido Y/genética , Neuropéptidos/genética , Orexinas , Hormonas Hipofisarias/genética , Embarazo , Prolactina/sangre , Prolactina/fisiología , Precursores de Proteínas/genética , ARN Mensajero/análisis , ARN Mensajero/metabolismo , Ratas , Ratas Sprague-Dawley
7.
Neuroendocrinology ; 69(1): 3-10, 1999 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-9892845

RESUMEN

Leptin is a hormone secreted by the adipocytes that regulates food intake and energy expenditure. It is known that growth hormone (GH) secretion is markedly influenced by body weight, being suppressed in obesity and cachexia, and recent data have demonstrated that GH release is regulated by leptin levels. Although one of the sites of action of leptin is likely to be the hypothalamus, since leptin receptor mRNA is particularly abundant in several hypothalamic nuclei, the mechanisms by which leptin regulates GH secretion are not yet known. The aim of the present study was to investigate whether leptin could act at the hypothalamic level modulating somatostatin and GH-releasing hormone (GHRH) expression. The administration of anti-GHRH serum (500 microl, i.v.) completely blocked leptin-induced GH release in fasting rats. In contrast, the treatment with anti-somatostatin serum (500 microl, i.v.) significantly increased GH release in this condition. Furthermore, leptin administration (10 microg, i.c.v.) to intact fasting animals reversed the inhibitory effect produced by fasting on GHRH mRNA levels in the arcuate nucleus of the hypothalamus, and increased somatostatin mRNA content in the periventricular nucleus. Finally, leptin administration (10 microgram, i.c.v.) to hypophysectomized fasting rats increased GHRH mRNA levels, and decreased somatostatin mRNA content, indicating an effect of leptin on hypothalamic GHRH- and somatostatin-producing neurons. These findings suggest a role for GHRH and somatostatin as mediators of leptin-induced GH secretion.


Asunto(s)
Hormona Liberadora de Hormona del Crecimiento/fisiología , Hormona del Crecimiento/metabolismo , Leptina/farmacología , Somatostatina/fisiología , Animales , Núcleo Arqueado del Hipotálamo/metabolismo , Ayuno , Privación de Alimentos , Hormona Liberadora de Hormona del Crecimiento/antagonistas & inhibidores , Hormona Liberadora de Hormona del Crecimiento/genética , Hipofisectomía , Hipotálamo/metabolismo , Sueros Inmunes , Leptina/administración & dosificación , Masculino , ARN Mensajero/metabolismo , Ratas , Ratas Sprague-Dawley , Somatostatina/genética , Somatostatina/inmunología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA